camostat has been researched along with Diabetes Mellitus in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T | 1 |
| Otsuki, M | 1 |
| Itoi, T | 1 |
| Shimosegawa, T | 1 |
| Funakoshi, A | 1 |
| Shiratori, K | 1 |
| Naruse, S | 1 |
| Kuroda, Y | 1 |
1 other study available for camostat and Diabetes Mellitus
| Article | Year |
|---|---|
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus; Esters; Female; Follow-Up Studies; Gabexate; Guan | 2007 |